Aurora Cannabis (ACB) Capital Expenditures (QoQ) (2017 - 2025)
Aurora Cannabis (ACB) Capital Expenditures (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 693.35% |
| Dec 31, 2024 | -4.42% |
| Sep 30, 2024 | 11.61% |
| Jun 30, 2024 | -118.07% |
| Mar 31, 2024 | 1,122.58% |
| Dec 31, 2023 | 34.70% |
| Dec 31, 2022 | -9.83% |
| Sep 30, 2022 | -71.92% |
| Jun 30, 2022 | 7.44% |
| Mar 31, 2022 | 44.05% |
| Dec 31, 2021 | -102.48% |
| Sep 30, 2021 | -105.72% |
| Jun 30, 2021 | 903.48% |
| Mar 31, 2021 | 9.82% |
| Dec 31, 2020 | 9.95% |
| Sep 30, 2020 | 51.67% |
| Jun 30, 2020 | 60.89% |
| Mar 31, 2020 | 35.63% |
| Dec 31, 2019 | -18.09% |
| Sep 30, 2019 | 83.33% |